China Jo-Jo Drugstores, Inc.
CJJD · NASDAQ
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $154,541 | $148,812 | $164,393 | $133,135 |
| % Growth | 3.8% | -9.5% | 23.5% | – |
| Cost of Goods Sold | $123,433 | $114,532 | $127,874 | $103,891 |
| Gross Profit | $31,109 | $34,280 | $36,519 | $29,244 |
| % Margin | 20.1% | 23% | 22.2% | 22% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $7,258 | $15,669 | $8,187 | $10,898 |
| SG&A Expenses | $34,643 | $44,846 | $39,064 | $37,853 |
| Sales & Mktg Exp. | $27,386 | $29,177 | $30,877 | $26,955 |
| Other Operating Expenses | $0 | $0 | $0 | $177 |
| Operating Expenses | $34,643 | $44,846 | $39,064 | $37,853 |
| Operating Income | -$3,535 | -$10,565 | -$2,545 | -$8,609 |
| % Margin | -2.3% | -7.1% | -1.5% | -6.5% |
| Other Income/Exp. Net | -$637 | $181 | $446 | $265 |
| Pre-Tax Income | -$4,171 | -$20,744 | -$2,099 | -$8,344 |
| Tax Expense | $63 | $395 | $1,100 | $32 |
| Net Income | -$4,234 | -$21,139 | -$3,198 | -$8,376 |
| % Margin | -2.7% | -14.2% | -1.9% | -6.3% |
| EPS | -2.93 | -41.46 | -220.62 | -49.29 |
| % Growth | 92.9% | 81.2% | -347.6% | – |
| EPS Diluted | -2.93 | -41.46 | -15.97 | -49.29 |
| Weighted Avg Shares Out | 1,444 | 510 | 14 | 170 |
| Weighted Avg Shares Out Dil | 1,444 | 510 | 200 | 170 |
| Supplemental Information | – | – | – | – |
| Interest Income | $517 | $884 | $402 | $708 |
| Interest Expense | $14 | $66 | $262 | $455 |
| Depreciation & Amortization | $5,385 | $718 | $1,256 | $1,813 |
| EBITDA | $1,227 | -$19,960 | -$580 | -$6,076 |
| % Margin | 0.8% | -13.4% | -0.4% | -4.6% |